Sangamo Therapeutics, Inc.
SGMO
$0.15
-$0.02-12.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.30% | -59.94% | -427.31% | 44.68% | 37.67% |
| Total Depreciation and Amortization | -54.42% | -11.80% | -10.77% | -26.27% | -23.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.86% | 676.64% | -26.53% | -66.11% | -51.87% |
| Change in Net Operating Assets | 12,884.42% | -126.54% | 161.17% | -16,707.14% | 98.97% |
| Cash from Operations | 26.26% | -628.23% | -342.35% | 32.46% | 46.27% |
| Capital Expenditure | -- | 90.79% | 44.35% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -101.06% | -127.47% | -118.90% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 161.35% | 110.04% | -- | -- | -54.00% |
| Repurchase of Common Stock | 82.98% | -58.64% | -31.53% | 21.20% | -453.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 228.24% | 111.66% | 9,560.10% | 5,468.48% | -63.23% |
| Foreign Exchange rate Adjustments | -159.98% | 101.78% | -96.27% | 1,163.04% | 290.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.66% | -452.59% | -172.13% | 147.79% | -293.97% |